WAGNER MARK T 4
4 · Miromatrix Medical Inc. · Filed Jun 29, 2021
Insider Transaction Report
Form 4
WAGNER MARK T
Director
Transactions
- Conversion
Common Stock
2021-06-28+3,334→ 3,334 total - Conversion
Series B-2 Preferred Stock
2021-06-28−3,334→ 0 totalFrom: 2021-05-21→ Common Stock (3,334 underlying)
Footnotes (1)
- [F1]Each share of Series B-2 Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.